Growth Metrics

Lexicon Pharmaceuticals (LXRX) Gains from Investment Securities (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Gains from Investment Securities for 5 consecutive years, with $43000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 91.06% to $43000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $3.2 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities for Q4 2025 was $43000.0 at Lexicon Pharmaceuticals, down from $1.6 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $2.9 million in Q2 2024, with the low at -$2.2 million in Q3 2024.
  • Average Gains from Investment Securities over 3 years is $451888.9, with a median of $572000.0 recorded in 2025.
  • Peak annual rise in Gains from Investment Securities hit 174.13% in 2025, while the deepest fall reached 91.06% in 2025.
  • Over 3 years, Gains from Investment Securities stood at $824000.0 in 2023, then plummeted by 41.63% to $481000.0 in 2024, then crashed by 91.06% to $43000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $43000.0, $1.6 million, and $989000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.